<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新药汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-10T16:31:42+08:00</updated>
  <subtitle>新药研发和临床试验交流和分享</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>NMPA：40个批文不予再注册！共115个药品注册证书注销！</title>
    <updated>2020-12-10T13:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/oRyPYmW53cLxG3RPCQcLQg</id>
    <link href="https://mp.weixin.qq.com/s/oRyPYmW53cLxG3RPCQcLQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅：有效率86%！中国疫苗在国外获批上市</title>
    <updated>2020-12-10T13:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/A4t9fP8e-94ZXsDJ40N5pQ</id>
    <link href="https://mp.weixin.qq.com/s/A4t9fP8e-94ZXsDJ40N5pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗肿瘤药物临床试验中心实验室使用专家共识2019版</title>
    <updated>2020-12-10T13:52:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/MKEDAEW7AZzHQAlHch3Otw</id>
    <link href="https://mp.weixin.qq.com/s/MKEDAEW7AZzHQAlHch3Otw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局综合司公开征求《药物警戒质量管理规范（征求意见稿）》意见</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/5TFiworJaonnsOnvT11qiQ</id>
    <link href="https://mp.weixin.qq.com/s/5TFiworJaonnsOnvT11qiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《单臂试验支持上市的抗肿瘤药进入关键试验前和上市许可申请前临床方面沟通交流技术指导原则》</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/oAyCGLHl_s8aTGSoK_7sdg</id>
    <link href="https://mp.weixin.qq.com/s/oAyCGLHl_s8aTGSoK_7sdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个新冠疫苗获批，离我们还有多远</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/BqT4nhoezAAMo5Haa3fnpw</id>
    <link href="https://mp.weixin.qq.com/s/BqT4nhoezAAMo5Haa3fnpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021EBC免费门票来袭！限量1000张</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/xMoF5-HIIkeCRUQfrY3GYw</id>
    <link href="https://mp.weixin.qq.com/s/xMoF5-HIIkeCRUQfrY3GYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药集团“first-in-class”抗体新药在中国获批临床</title>
    <updated>2020-12-04T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/cxROVOr-oCdntm0dUFV0Ag</id>
    <link href="https://mp.weixin.qq.com/s/cxROVOr-oCdntm0dUFV0Ag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家药监局发布《真实世界数据用于医疗器械临床评价技术指导原则（试行）》</title>
    <updated>2020-11-26T11:24:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/5gXTJNH9N6xWhbwVG4rcnw</id>
    <link href="https://mp.weixin.qq.com/s/5gXTJNH9N6xWhbwVG4rcnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新指南《临床试验设计六大核心要素之一：人群》推荐适应性设计和富集设计</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/T4jrZVrNoeV4H5NbFESXwA</id>
    <link href="https://mp.weixin.qq.com/s/T4jrZVrNoeV4H5NbFESXwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国非公立医疗机构协会正式“加盟”！ 重磅助力2020南京国际生命健康大会暨博览会</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/Y-esLahfLOoISGDT10B_yg</id>
    <link href="https://mp.weixin.qq.com/s/Y-esLahfLOoISGDT10B_yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《疫苗临床试验抗体分析方法研究技术指导原则》征求意见稿</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/2AaqgRf4xT5b4ReLUHDlnQ</id>
    <link href="https://mp.weixin.qq.com/s/2AaqgRf4xT5b4ReLUHDlnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产「药王」新适应症获批，八成原研市场进一步被瓜分</title>
    <updated>2020-11-25T16:09:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/HQqv1g8OiNGQu5SdFnIPDA</id>
    <link href="https://mp.weixin.qq.com/s/HQqv1g8OiNGQu5SdFnIPDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《化学药品创新药I期临床试验申请药学共性问题相关技术要求》和《化学药品I期临床试验申请药学研究信息汇总表（修订版）》</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/wQn2L7tQ3l72ok8CvraLpw</id>
    <link href="https://mp.weixin.qq.com/s/wQn2L7tQ3l72ok8CvraLpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>指南 | WHO《临床试验用药GMP指南》2020征求意见稿</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/p0Uoy85eGFtbG3Qzc4jjoQ</id>
    <link href="https://mp.weixin.qq.com/s/p0Uoy85eGFtbG3Qzc4jjoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“绝代双骄，联动未来” SciVario® twin双联生物反应器重磅上市，助力生物制药行业高质量发展</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/83uZm9pdZKdUrf8EshD1mQ</id>
    <link href="https://mp.weixin.qq.com/s/83uZm9pdZKdUrf8EshD1mQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州「地舒单抗」新适应症获批！国内首款骨转移及骨相关事件 RANKL 抑制剂</title>
    <updated>2020-11-23T15:53:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/FBPNGJXdLbLnVGYwzB32Qw</id>
    <link href="https://mp.weixin.qq.com/s/FBPNGJXdLbLnVGYwzB32Qw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE重磅利好！药品临床期间即可申请批准！《药品附条件批准上市技术指导原则（试行）》即日执行</title>
    <updated>2020-11-20T14:26:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/UpQy88TmLkW2L-bxzEdKzQ</id>
    <link href="https://mp.weixin.qq.com/s/UpQy88TmLkW2L-bxzEdKzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布第三批临床急需境外新药名单</title>
    <updated>2020-11-20T14:26:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/Rpje6amUzdq7r9emjvg1Cw</id>
    <link href="https://mp.weixin.qq.com/s/Rpje6amUzdq7r9emjvg1Cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业「恩莎替尼」获批上市，首个国产 ALK 抑制剂</title>
    <updated>2020-11-19T15:44:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/7o1wfT-6am3bW3IESaxbug</id>
    <link href="https://mp.weixin.qq.com/s/7o1wfT-6am3bW3IESaxbug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>